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Abstract
The synthetic, cell penetrating hexapeptide PAF26 (RKKWFW) is antifungal at low micromolar concentrations and has been
proposed as a model for cationic, cell-penetrating antifungal peptides. Its short amino acid sequence facilitates the analysis
of its structure-activity relationships using the fungal models Neurospora crassa and Saccharomyces cerevisiae, and human
and plant pathogens Aspergillus fumigatus and Penicillium digitatum, respectively. Previously, PAF26 at low fungicidal
concentrations was shown to be endocytically internalized, accumulated in vacuoles and then actively transported into the
cytoplasm where it exerts its antifungal activity. In the present study, two PAF26 derivatives, PAF95 (AAAWFW) and PAF96
(RKKAAA), were designed to characterize the roles of the N-terminal cationic and the C-terminal hydrophobic motifs in
PAF26’s mode-of-action. PAF95 and PAF96 exhibited substantially reduced antifungal activity against all the fungi analyzed.
PAF96 localized to fungal cell envelopes and was not internalized by the fungi. In contrast, PAF95 was taken up into
vacuoles of N. crassa, wherein it accumulated and was trapped without toxic effects. Also, the PAF26 resistant Darg1 strain
of S. cerevisiae exhibited increased PAF26 accumulation in vacuoles. Live-cell imaging of GFP-labelled nuclei in A. fumigatus
showed that transport of PAF26 from the vacuole to the cytoplasm was followed by nuclear breakdown and dissolution.
This work demonstrates that the amphipathic PAF26 possesses two distinct motifs that allow three stages in its antifungal
action to be defined: (i) its interaction with the cell envelope; (ii) its internalization and transport to vacuoles mediated by
the aromatic hydrophobic domain; and (iii) its transport from vacuoles to the cytoplasm. Significantly, cationic residues in
PAF26 are important not only for the electrostatic attraction and interaction with the fungal cell but also for transport from
the vacuole to the cytoplasm, which coincides with cell death. Peptide containment within vacuoles preserves fungal cells
from peptide toxicity.
Citation: Mun˜oz A, Harries E, Contreras-Valenzuela A, Carmona L, Read ND, et al. (2013) Two Functional Motifs Define the Interaction, Internalization and Toxicity
of the Cell-Penetrating Antifungal Peptide PAF26 on Fungal Cells. PLoS ONE 8(1): e54813. doi:10.1371/journal.pone.0054813
Editor: Gustavo Henrique Goldman, Universidade de Sao Paulo, Brazil
Received July 13, 2012; Accepted December 17, 2012; Published January 21, 2013
Copyright:  2013 Mun˜oz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: AM was funded by the Postdoctoral Mobility Program of Ministerio de Ciencia e Innovacio´n (MICINN, Spain). EH fellowship and short stay at the
University of Edinburgh were funded by the JAE-PREDOC Program of Consejo Superior de Investigaciones Cientı´ficas (CSIC, Spain). ACV was funded by the
Consejo Nacional de Ciencia y Tecnologı´a (CONACYT, ME`xico). The work was supported by research grants BB/E010741/1 from Biotechnology and Biological
Sciences Research Council (BBSRC, U.K.) and grant #093596/B/10Z from the Wellcome Trust to NDR, and BIO2009-12919 from MICINN (Spain) and ACOMP2012-
018 (Generalitat Valenciana, Valencia, Spain) to JFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jmarcos@iata.csic.es (JFM); Nick.Read@ed.ac.uk (NDR)
Introduction
Antimicrobial peptides (AMPs) and proteins are being inten-
sively studied as alternatives for the control of microorganisms in
medical, agricultural and food preservation applications [1–4].
Nearly all AMPs are cationic and amphipathic molecules with the
capability of interacting with and disrupting anionic biological
membranes, which potentially enable them to permeabilize and
lyse living microbial cells. In the last decade, however, it has
become clear that some AMPs also have additional effects on their
target microbial cells in vivo, including more subtle and specific
intracellular mechanisms [5–11].
Various AMPs have been demonstrated to translocate across
the plasma membrane non-disruptively at low to moderate
concentrations and result in a variety of different intracellular
effects [12–17]. AMPs with these characteristics share biophysical
properties with the so-called cell penetrating peptides (CPPs). This
has brought into question the differences between antimicrobial
and cell penetrating activities [18] and led to the definition of a
new class of cell penetrating AMPs (CP-AMPs) [4]. Peptides
initially known as CPPs, and also found to be taken up into
mammalian cells, were later demonstrated to exhibit antimicrobial
activity towards distinct microorganisms, and this activity corre-
lated with internalization of the CPPs by the microbial cells
[19,20]. However, the link between penetration and antimicrobial
properties requires further analysis. Interestingly, for selected
AMPs such as the proline-rich apidaecin, the microbial internal-
ization and killing activities seem to be separated, and peptide
uptake was necessary but not sufficient for antibacterial activity
[12]. An attractive hypothesis, therefore, is that this class of
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bioactive peptides are in fact dual molecules in which internali-
zation determinants do not necessarily overlap with antimicrobial
activity [6]. Experiments should address the identification of these
(separate) determinants in model AMPs in order to establish the
minimum amino acid sequence requirements for these different
activities, if present. This should help in the design of ‘‘modular’’
domains with distinct functional capabilities for custom-designing
improved AMPs in the future.
PAF26 is a synthetic, tryptophan-rich, cationic hexapeptide that
was previously identified by a combinatorial approach against the
fungal plant pathogen Penicillium digitatum [21]. It has been shown
to enter cells of P. digitatum and perturb cell morphogenesis prior to
cell permeabilization, but it is not lytic or cytotoxic to human cells
[22,23]. Recently, PAF26 entry routes into fungal cells were
analyzed in detail using live-cell imaging techniques in the model
filamentous fungus Neurospora crassa [17]. This study demonstrated
endocytic internalization of PAF26 prior to killing fungal cells,
when the peptide was applied at low fungicidal concentrations.
PAF26 is therefore a CP-AMP that possesses the determinants for
both antifungal and cell penetrating activities in just six amino acid
residues, and we have proposed it as a useful model to analyze
these two activities as well as the relationships between them.
Treatment of Saccharomyces cerevisiae with sublethal concentra-
tions of peptides demonstrated the differential effects of the CP-
AMP PAF26 and the cytolytic peptide melittin at the transcrip-
tional level [24]. This study showed increased expression of genes
involved in strengthening of the cell wall (a common response to
different AMPs), arginine metabolism, ribosomal biogenesis and
the unfolded protein stress response [24]. Deletion of specific genes
altered the sensitivity of the yeast to PAF26. For instance, deletion
of the ARG1 gene that encodes the cytosolic arginine succinate
synthetase in the arginine biosynthetic pathway, as well as the
deletion of other ARG genes, resulted in increased resistance to
PAF26. Recently, increased endogenous nitric oxide (NO)
production in the budding yeast was shown in response to
PAF26 treatment and NO production correlated with peptide
toxicity [25]. In addition, arginine-derived NO production was
blocked in the Darg1 mutant, providing a plausible explanation for
its resistant phenotype.
In this study we took advantage of the small size and defined
amino acid sequence of PAF26 to characterize the influence of the
cationic N-terminal and the hydrophobic C-terminal motifs in its
modes of internalization, intracellular transport and antifungal
activity. By using PAF26 sequence analogs and analyzing their
inhibitory activities and subcellular locations, we have defined
three steps in PAF26 mode-of-action which are conserved in
different fungi (the fungal models Neurospora crassa and Saccharomyces
cerevisiae, and the human fungal pathogen Aspergillus fumigatus). We
show that the peptide first encounters and interacts with the cell
envelope (cell wall and/or the plasma membrane), subsequently
enters the fungal cell, is transported to the vacuole, and finally
exerts its killing activity after being transported to the cytoplasm.
Results
Both cationic and hydrophobic motifs are needed for
PAF26 activity
The antifungal peptide PAF26 was identified through a
synthetic combinatorial hexapeptide library screen against phyto-
pathogenic fungi [21]. Its sequence is optimized in terms of
antifungal potency, high selectivity for fungi [26] and lack of
toxicity towards human cells [22,23]. Interestingly, two motifs are
present in the PAF26 sequence: a cationic N-terminus (RKK) and
a C-terminus composed of hydrophobic, aromatic amino acids
(WFW), which together conform an amphiphilic AMP (Table 1).
In this study, we designed two derivatives of PAF26 to characterize
the roles of these N- and C-terminal regions in its antifungal
properties. PAF95 was designed to neutralize the strong cationic
N-terminal half of the peptide by substituting its three residues
with neutrally charged Ala residues. Similarly, the C-terminus was
modified in PAF96 by replacing the hydrophobic amino acids with
Ala residues. As expected, the isolelectric point and net charge of
PAF95 were strongly reduced while the hydropathicity index
(GRAVY) also changed significantly for both derivatives (Table 1).
Following a previous analysis of the mechanisms of PAF26 cell
penetration in the filamentous fungus N. crassa [17], we used this
eukaryotic model to characterize the novel derivatives PAF95 and
PAF96. A substantial reduction in the fungistatic and fungicidal
activities of both new peptides in comparison with the parental
peptide PAF26 was observed (Figure 1). Complete inhibition of
conidial germination was achieved at $5 mM in the case of
PAF26, whereas at a concentration of 30 mM, 7468% and
5666% germination were observed in the presence of PAF95 and
PAF96, respectively (Figure 1A). Little or no killing of N. crassa
conidia was observed after treatment with up to 20 mM of PAF95
or PAF96 (Figure 1B). This contrasted with the strong fungicidal
activity of PAF26, which at 2.5 mM killed 81% of conidia.
In N. crassa cells the interaction and localization of PAF
peptides are dependent on specific amino acid motifs
Confocal microscopy of fluorescently labeled peptides has
allowed the visualization of AMP internalization by microbial
cells [13,27–30,17]. The PAF peptides were covalently labelled at
their N-termini with the red fluorophore tetramethyl-rhodamine
(TMR) as part of the synthetic procedure. Labeling of PAF26 with
the TMR fluorescent label did not significantly influence the
activity of PAF26 [17].
The three peptides, each at a concentration of 5 mM exhibited
different localization patterns with cells of N. crassa after 1 h of
treatment (Figures 2 and S1). At this lethal peptide concentration
(Fig. 1), TMR-PAF26 was detected throughout both conidia and
germ tubes that became highly vacuolated and died (Figure 2B).
Quantification revealed that 9862% of the conidial population
showed this characteristic staining pattern with TMR-PAF26
(Figure 2A). The non-active TMR-PAF95 that possessed the
hydrophobic motif but lacked the cationic motif, was internalized
by 56610% of conidia. It accumulated within intracellular
organelles that resembled the vacuolar system (see below) but
did not stain the cell envelope or cytoplasm (Figure 2 and
Figure S1). The remaining 4368% of conidia showed no TMR-
PAF95 labeling (Figure 2A). On the other hand, the non-active
TMR-PAF96, that possesses the cationic but not hydrophobic
motif, remained bound to the cell envelope (either or both the cell
wall and the plasma membrane) and was not internalized by any
of the conidia tested (Figure 2A, B).
Table 1. Peptides used in this study.
Peptide Sequence MWa Net chargea pIa GRAVYa
PAF26 RKKWFW 950.1 +3 11.17 21.883
PAF95 AAAWFW 750.8 0 5.57 1.067
PAF96 RKKAAA 643.7 +3 11.17 21.150
aCalculated values according to ProtParam at the Expasy Server (www.expasy.
org).
doi:10.1371/journal.pone.0054813.t001
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Further experiments were designed to better characterize the
subcellular location of the TMR-labelled PAF95 and PAF96
peptides by using them in combination with other fluorescent
reporters of cell walls and organelles. The vacuolar localization of
TMR-PAF95 was confirmed by co-localizing the peptide with the
vacuolar probe cDFFDA (Oregon Green 488 carboxylic acid)
(Figure 3A). Staining the cell walls with the chitin binding probe
calcofluor white (CFW) and co-labelling with TMR-PAF96
showed regions of the cell envelope where the staining of the
cell wall was exterior to the TMR-peptide labeling (Figure 3B, see
inset box). This indicates that the TMR-PAF26 will initially
interact with the outer region of the cell wall (as it is the first
encountered layer) and would subsequently reach the inner region
of the cell wall and/or plasma membrane.
PAF26 is fungicidal to and internalized by cells of the
human pathogen Aspergillus fumigatus
We also explored the use of PAF26 as a candidate AMP to
control the human pathogen A. fumigatus. We tested the PAF26
inhibitory activity towards A. fumigatus in an assay in which
ungerminated conidia were exposed to increasing concentrations
of the peptide and incubated for 5 h. At 37uC in liquid Vogel’s
growth medium, 95% of untreated conidia underwent isotropic
growth and germinated to produce germ tubes. A significant
reduction in germination occurred when conidia were treated
with 1–5 mM PAF26, while 10 mM PAF26 completely inhibited
germination (Figure 4A). Similar to N. crassa, conidial germina-
Figure 1. Dose-response curves of the effects of the PAF
peptides on conidial germination and viability of conidia of N.
crassa. (A) Percentage of germinated conidia was quantified by light
microscopy 3 h after treatment with the peptides. (B) Percentage of
viable cells after 3 h of peptide treatment was quantified using the cell
death marker propidium iodide. The peptides used were PAF26 (black
circles), PAF95 (white triangles) and PAF96 (white squares).
doi:10.1371/journal.pone.0054813.g001
Figure 2. Localization of fluorescently labeled PAF peptides in
N. crassa cells. (A) Percentage of conidial population that do not show
any TMR-peptide fluorescence signal (class ‘‘0’’, striped bars), or show
TMR-peptide fluorescence limited to cell envelopes (class 1, white bars),
intracellular organelles (class 2, light grey bars), or filling the whole
cytoplasm of the cells (class 3, black bars), after 1 h of treatment with
5 mM of each of the TMR-peptides. (B) Representative confocal images
showing the localization of TMR-PAF26, TMR-PAF95 and TMR-PAF96 (in
red) in conidia (left panels) and conidial germlings (right panels). For
each peptide, the most common pattern of localization is shown (see
A). Bars: 2 mm in conidia and 5 mm in germlings.
doi:10.1371/journal.pone.0054813.g002
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tion in A. fumigatus was not significantly inhibited by the two
PAF26 derivatives, PAF95 and PAF96 (Figure 4A).
To characterize the interaction of PAF26 with conidial
germlings of A. fumigatus, we exposed TMR-labelled peptides to
a strain in which nuclei were labelled with GFP fused to the
histone H1 (Figures 4B and 5). After incubation for 1 h with
each of the peptides at a concentration of 5 mM, only the
germlings treated with TMR-PAF26 were uniformly fluorescently
stained throughout and were dead. Consistent with this, $95%
of TMR-PAF26 treated germlings lacked any nuclear staining
whilst those treated with TMR-PAF95 or TMR-PAF96 exhibited
normal GFP nuclear labeling providing further evidence of
PAF95 and PAF96 lacking antifungal activity (Figure 4B). Similar
evidence of the nuclear breakdown coincident with a cytosolic
PAF26 signal was also reported previously in a N. crassa GFP-H1
strain [17]. However, in marked contrast to what occurs in N.
crassa (Figures 2B and 3A), we could not detect any signal of the
inactive TMR-PAF95 within conidia or germ tubes of A.
fumigatus. In N. crassa, TMR-PAF95 penetrated and was
compartmentalized within the vacuolar network of 56610% of
cells (Figure 2A). This suggests significant differences with regard
to the interaction of PAF95 with N. crassa and A. fumigatus
germlings. In the former, the inactive peptide was able to interact
and penetrate a proportion of the cell population while in the
latter (Figure 5B) no interaction of PAF95 with cells could be
observed. On the other hand, PAF96 behaved similarly in both
fungi being located at the cell envelope with no evidence of cell
penetration (compare Figures 2B and 4B).
Germinated and ungerminated conidia were treated with
inhibitory concentrations of TMR-PAF26 and analyzed by time-
lapse confocal microscopy. After 5–14 min of exposure to TMR-
PAF26, faint red fluorescence indicative of peptide internaliza-
tion were detected within spherical vacuoles which increased in
size and intensity between 14 and 30 min (see arrows in
Figure 5A and B). A total absence of co-localization between
H1-GFP and TMR-PAF26 was observed. Towards the end of
this 30 min period the green nuclear fluorescence in some of the
nuclei started to disappear (see asterisks in Figure 5, Movie S1),
indicating chromatin dissolution and probably cell death. At
longer times of peptide treatment (,1 h), TMR-PAF26 was seen
to be transported from the vacuoles to the cytosol resulting in
intense staining throughout the cells, and this was associated with
the breakdown and dissolution of the nuclei and death of all of
the cells (see PAF26 panel in Figure 4B and time course of
Figure 5C).
Figure 3. Subcellular localization of PAF95 and PAF96 in
conidial germlings of N. crassa. (A) Co-localization of TMR-PAF95 (in
red) with the vacuolar marker cDFFDA (in green) after treatment of the
germlings with 5 mM TMR-PAF95 for 1 h. Note co-localization within the
vacuolar network in these merged images. (B) Localization of TMR-
PAF96 (in red) and the cell wall stain CFW (in blue) after treatment with
TMR-PAF96 for 1 h. Note that in regions of the cell envelope the
calcofluor white staining is exterior to that of the TMR-PAF96 labelling
(see inset) in the merged image. Bar: 5 mm.
doi:10.1371/journal.pone.0054813.g003
Figure 4. Activity and localization of PAF peptides in A.
fumigatus. (A) Influence of PAF peptides on conidial germination.
Percentage of germinated conidia was quantified by microscopy ,5 h
after treatment with the peptides at different concentrations. (B)
Confocal microscopy of the localization of 5 mM TMR-labeled peptides
(in red) in germlings of A. fumigatus expressing H1-GFP (in green) 1 h
after treatment with the three peptides. Note that the left hand panels
show brightfield images of germlings and the right panels show
corresponding GFP-labeled nuclei in the same cells. The germlings were
all treated for 1 h with the different PAF peptides before imaging. Note
that the whole germlings treated with TMR-PAF26 are labeled by the
fluorescent peptide, lack nuclei and are dead. This contrasts with both
the TMR-PAF95 and TMR-PAF96 treated germlings that possess nuclei
and are alive. The TMR-PAF95 treated germlings lack any labeling with
the fluorescent peptide whilst TMR-PAF96 is bound only to the cell
envelope of the germlings. Bar: 10 mm.
doi:10.1371/journal.pone.0054813.g004
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Figure 5. Interaction and internalization of TMR-PAF26 in A. fumigatus. (A) Sequential images show the interaction and internalization of
5 mM TMR-PAF26 (in red) in actively growing conidial germlings of A. fumigatus expressing H1-GFP (in green) over a period of 25 min. (B) Detail of a
germling present in (A) showing merged fluorescent and brightfield images. Note accumulation of TMR-PAF26 in vacuolar compartments (arrows)
which undergo expansion and become more intensely fluorescent with time. This coincided with the initiation of the breakdown and loss of
fluorescence of the nuclei (asterisks). (C) Detailed images of a germling undergoing these effects over a period of 5 min recorded 50 min after
peptide addition. See also Movie S1 for the entire sequential time course of panel (A). Bar: 10 mm in (A) and 4 mm in (B) and (C).
doi:10.1371/journal.pone.0054813.g005
Functional Motifs in the Antifungal Peptide PAF26
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The unicellular model fungus Saccharomyces cerevisiae
also shows differential susceptibility and interaction with
the PAF peptides
We have previously reported that PAF26 shows antifungal
activity against S. cerevisiae and that FITC-PAF26 is internalized by
yeasts cells [24]. Similar to the results reported above for N. crassa
and A. fumigatus, PAF95 and PAF96 showed a very significant
reduction in antifungal activity against S. cerevisiae compared with
that of PAF26 (Figure 6A).
Confocal microscopy showed that TMR-PAF26 exhibited
different patterns of staining within the population of yeast cells
of the reference strain BY4741 (Figure 6B). With 2.5 mM TMR-
PAF26, 15–25% of cells had only their cell envelopes labeled, 60–
75% showed labeling of their cell envelopes and also discrete
intracellular vacuole-like structures, and 3–20% exhibit intense red
staining throughout the cell and this correlated with cell death
(Figure 7A). Localization of TMR-PAF26 within vacuole-like
structures was coincident with that of the vacuolar probe cDFFDA
(data not shown). TMR-PAF95 lacking the cationic motif did not
stain these wild type cells at all, similar to the result obtained with
A. fumigatus (Figure 4B), and TMR-PAF96 that lacked the
hydrophobic motif exclusively labeled the cell envelope of yeast
cells (Figure 6B). When TMR-PAF95 and TMR-PAF96 peptides
were applied for longer times of incubation (i.e., 1 h, similarly to
the A. fumigatus experiment in Figure 4B) and higher concentra-
tions (up to 25 mM), the result was identical (data not shown)
consistent with a complete lack of interaction (PAF95) or
internalization (PAF96) of these peptides.
A previous genomic approach identified S. cerevisiae mutants
with specific gene deletions that showed altered sensitivities to
PAF26 (Table 2) [24]. They correspond to: (1) IPT1 that encodes a
specific membrane sphingolipid; (2) several ARG genes from the
urea cycle and metabolism of arginine (including ARG1); and (3)
ECM33, which encodes a major cell wall GPI-anchored protein of
unknown function. The mutant Decm33 possesses a weakened cell
wall and shows increased sensitivity to PAF26. In contrast, gene
deletions of either IPT1 or ARG1 resulted in increased resistance to
PAF26 [24]. Interaction of TMR-PAF26 with the S. cerevisiae Darg1
or Decm33 mutants showed a significantly different distribution of
the TMR-PAF26 signal from that of the wild type BY4741 strain
or Dipt1 strain (Figure 7A). Representative micrographs are shown
to illustrate that the TMR-PAF26 fluorescence detected in Darg1
cells was mostly located in discrete vacuolar organelles and at a
higher frequency than in BY4741 cells. In contrast, Darg1 cells
exhibiting TMR-PAF26 staining throughout their cells were
scarce and this was coincident with the lower sensitivity of this
strain to PAF26 (Figure 7B). On the other hand, the complete
staining of cells with TMR-PAF26 in Decm33 cells was significantly
more frequent (p,0.01) than the other strains, and this correlated
with the higher sensitivity of this mutant to the peptide [24]. The
three patterns of TMR-PAF26 distribution within cells of the Dipt1
strain were not significantly different to that of the wild type
BY4751 strain. Staining of the three mutant strains with TMR-
PAF95 or TMR-PAF96 produced similar results to those obtained
with BY4741 cells (data not shown).
Discussion
We have used the synthetic PAF26 peptide as a model CP-AMP
to analyze the determinants of both antifungal and cell penetrating
activities of AMPs. This rationale is facilitated by: (i) its small size;
(ii) use of sequence analogs of PAF26 that show different activities
[23,26]; and (iii) the availability of mutants of S. cerevisiae [24,25]
and N. crassa [17] that show altered susceptibility to the peptide.
This study provides significant new evidence demonstrating the
intracellular mode-of-action of PAF26. It also shows that
interaction and internalization of the derivatives of PAF26 (i.e.
PAF95 and PAF96) per se do not result in cell death. Our data
clearly define three steps which are necessary but not sufficient for
PAF26 fungicidal action: (1) a cationic motif-mediated interaction
of the peptide with cell envelopes that is also influenced by fungal
cell wall components; (2) tryptophan-mediated internalization; and
(3) intracellular toxicity which is linked to the cationic charge of
the peptide and active transport from the vacuoles into the cytosol.
In a previous study, an alanine scan experiment in which each
amino acid of the PAF26 sequence was substituted by alanine was
carried out to determine the contribution of each residue to the
peptide’s antimicrobial activity [26]. The main conclusion was that
no single substitution is a determinant for activity, since all the
residues contributed individually to some extent. It was also
evident that any cationic amino acid (Arg, Lys) exhibits a
Figure 6. Activity and localization of PAF peptides in yeast. (A)
Serial 5-fold dilutions of exponentially growing S. cerevisiae BY4741 cells
treated with 64 mM of each peptide for 24 h, and subsequently plated
onto YPD peptide-free plates. (B) Brightfield (images on the left) and
corresponding confocal microscopy (images on the right) showing the
localization in yeast cells (16106 cells/ml) after treatment with 2.5 mM
of each of the TMR-labeled peptides (in red) for 30 min. Bar: 10 mm.
doi:10.1371/journal.pone.0054813.g006
Functional Motifs in the Antifungal Peptide PAF26
PLOS ONE | www.plosone.org 6 January 2013 | Volume 8 | Issue 1 | e54813
quantitatively more important contribution than aromatic residues
(Trp, Phe). As an alternative approach, two new hexapeptides
were designed for the present study in which either the cationic
domain (RKK) or hydrophobic domain (WFW) was removed and
replaced with three alanine residues to produce the two PAF26
derivatives, PAF95 and PAF96, respectively. Our study clearly
demonstrated that both domains are necessary for antifungal
toxicity. Neither PAF95 nor PAF96 showed significant antifungal
activity towards N. crassa (Figure 1), A. fumigatus (Figure 4A), S.
cerevisiae (Figure 6A) or the plant pathogen P. digitatum (Figure S2).
It is obvious that these substitutions greatly modified the
physicochemical properties of the parental peptide PAF26
(Table 1), including the cationic charge that has been previously
reported as critical for the activities of most AMPs [5,7–10]. A
substantial detrimental effect was thus anticipated. However, the
different localization patterns of the three PAF peptides led to
significant new conclusions on the roles of the two main domains
of PAF26 in binding to the cell envelope, cell penetration,
transport to the vacuole, transport out of the vacuole and its
antifungal activity.
The use of the model filamentous fungus N. crassa represents a
very amenable experimental system for which a broad range of
live-cell imaging techniques are available [31,32]. PAF26 was
internalized by N. crassa germlings and eventually after long-term
(1 h) exposure to the peptide it was localized throughout cells and
this coincided with cell death (Figure 2B). A recent study has
described in detail the kinetics and internalization mechanisms of
PAF26 into this model fungus [17]. The mode of PAF26 uptake by
cells was shown to be concentration dependent with endocytic
internalization playing a predominant role at low fungicidal
concentrations and passive translocation at higher concentrations.
Endocytically internalized PAF26 accumulated in vacuoles and
was then actively transported into the cytoplasm where it exerted
its antifungal activity. In the present study, PAF95 and PAF96
showed distinctly different localization patterns to PAF26 within
living cells of N. crassa (Figure 2), which demonstrated the different
roles of the two PAF26 motifs during its dynamic internalization
process.
Neurospora crassa was unique in that it was the only fungus out of
the four analyzed in which TMR-PAF95 was internalized in a
significant number of cells (50–60% of conidia, Figures 2A and
S1). Co-localization with the vacuolar stain cDFFDA showed that
PAF95 was localized in the vacuolar system (Figure 3). In the other
three fungi (S. cerevisiae, A. fumigatus and P. digitatum), TMR-PAF95
was not internalized (Figures 4 and 6, and data not shown).
Positive charge is recognized as a key driving force for AMP
activity because it promotes interaction with negatively charged
microbial surfaces, and our data confirm this for all the fungi
analyzed. The behavior of PAF95 in N. crassa suggests that
additional, unknown cell envelope factors exist in this fungus,
which allow the interaction, penetration and transport of a non-
cationic peptide as far as the vacuole, albeit with less efficiency
than PAF26. We hypothesize that these uncharacterized fungal
cell wall/plasma membrane factors that facilitate the interaction of
PAF95 would: (i) interact with the aromatic tryptophan and/or
phenylalanine residues in the hydrophobic domains of PAF26 and
PAF95, and (ii) relate to the observed increased sensitivity and
faster inhibitory responses of N. crassa exposed to PAF26, as
compared to other fungi (compare Figures 1A, 4A, and S2).
Factors that reside in the cell wall and/or the plasma membrane
may not only facilitate the interaction of certain AMPs with the
fungal cell but they could also mask receptors/target molecules
that the AMPs may interact with in this cell region. Examples of
possible ‘masking’ molecules include cell wall glycoproteins that
increase the resistance of Fusarium oxysporum to osmotin [33] and
stress proteins of the PIR family that reduce the inhibitory activity
of osmotin towards S. cerevisiae [34]. This may provide an
alternative explanation for the increased resistance of A. fumigatus,
S. cerevisiae and P. digitatum towards PAF26 compared to N. crassa
that is highly sensitive to PAF26.
Figure 7. Differential localization of TMR-PAF26 in different S.
cerevisiae strains. (A) Graph showing the percentage of cells that
show TMR-PAF26 fluorescence limited to the cell envelope (class 1,
white bars), in intracellular organelles (class 2, light grey bars), or filling
whole cells (class 3, black bars), after treatment for 1 h with the peptide
for each strain (as labeled on the x-axis). Cell location was determined
by confocal microscopy. Results represent the means 6 standard
deviations of three experiments, each performed in triplicate. Dots
above bars indicate statistical significance as compared to each class in
the BY4741 parental strain control. Black dots indicate percentage lower
than BY4741 and white dots higher. Two dots indicate p,0.01, and one
dot p,0.05. (B) Representative confocal microscopy images are shown
from the data set quantified in (A). Two examples of classes 1, 2 and 3
are labelled in strain BY4741. Bar: 10 mm.
doi:10.1371/journal.pone.0054813.g007
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Remarkably, PAF96 labeled the cell envelopes in 100% of the
cells of all the fungi analyzed and thus the cationic domain (PAF96
possesses only this domain) is involved in the interaction of PAF26
with this cell component. However, in N. crassa only, a cationic
interaction is not essential for internalization because PAF95
(which lacks the cationic domain) is still internalized. Double
labeling of TMR-PAF96 with the cell wall stain CFW indicated
that PAF96 possibly associates with either the inner part of the
thickened cell wall or at the plasma membrane (Figure 3B). This
demonstrates that the peptide is at least able to diffuse through the
cell wall. These observations, in conjunction with the lack of
antifungal activity of PAF96, demonstrate that PAF26 does not
exert its antifungal killing action at the cell surface, although the
cell surface might be required for the interaction and thus
antifungal activity as recently characterized in the antifungal plant
defensin NaD1 [35]. PAF96 lacks the tryptophan-phenylalanine-
tryptophan C-terminal tail of PAF26. The importance of
tryptophan residues for the antibacterial activity of AMPs has
been recognized [36] and they have been shown to facilitate the
interaction with model micelles [37]. Recently, addition of
tryptophan/phenylalanine motifs to short and cationic AMPs
was shown to enhance bacterial killing [38], and also increase
selectivity by lowering the toxicity to human epithelial and red
blood cells [39]. PAF26 has been previously demonstrated to cause
unusually low hemolysis and toxicity to human cells in cell culture
[23]. Our work reveals that tryptophan residues are also involved
in the internalization of this class of AMPs by fungal cells. In the
previous alanine scan experiment with PAF26, the substitution of
phenylalanine at position 5 (see Table 1) by alanine had only a
minimal effect on antifungal activity [26]. This result indicates that
phenylalanine is not likely to have a major role in peptide
internalization/activity, and therefore points towards tryptophan
being the critical residue required for cell penetration of PAF26
into fungal cells. Failure to enter microbial cells has been related to
the lack of antimicrobial activity for other inactive AMP analogs
such as derivatives of buforin II in E. coli [13], histatin 5 in C.
albicans [40] and Sub5 in A. nidulans [41]. Only Sub5 contains
tryptophan residues. It was shown that the amino acid substitu-
tions that disrupted Sub5 antifungal activity involved tryptophan
as well as arginine, lysine and valine residues, and therefore it was
not possible to assign the observed phenotype to any specific
amino acid change.
Although membrane lytic mechanisms are recognized as the
primary mode-of-action for the majority of AMPs, increasing
evidence supports the existence of AMPs, which exert an array of
multifactorial effects including other specific interactions with the
cell envelope as well as intracellular targets [5,7–10]. In a previous
study a transcriptomic approach was used with the model yeast S.
cerevisiae to characterize the mode-of-action of PAF26 in compar-
ison with the cytolytic peptide Melittin [24]. In the present study,
we determined the sub-cellular location of PAF26 using high
resolution confocal microscopy of three representative S. cerevisiae
knockout strains previously identified as exhibiting increased
resistance or sensitivity to PAF26 (Table 2). Our analyses
correlated the percentage of cells in the cell population exhibiting
complete cell labeling by TMR-PAF26 with differences in the
sensitivity of the Darg1 and Decm33 mutants to PAF26 (Figure 7).
They also revealed that the disruption of ARG1 is linked to
increased PAF26 accumulation in intracellular vacuolar-like
organelles which correlates with increased resistance to the
antifungal activity of the peptide. Arg1p is a cytosolic enzyme,
fundamental to the biosynthesis or arginine, metabolism/recycling
of amino groups and the urea cycle. Moreover, blockage of the
endogenous NO production derived from arginine was related to
the PAF26-resistant phenotype of the Darg1 yeast mutant [25].
Interestingly, the inactive PAF95 does not contain arginine
residues and was trapped within vacuoles of N. crassa, wherein it
was not toxic to fungal cells. Analyses of the kinetics of
internalization of PAF26 [17] and histatin 5 [15,42] indicated
that the active transport from vacuoles to the cytosol is
concomitant with cell killing. In the proline-rich AMP apidaecin,
the internalization by bacteria and their killing were also separated
and uptake into cells was necessary but not sufficient for
antimicrobial activity of selected analogs [12]. From the available
data we can hypothesize that containment of PAF26 and PAF95
within vacuoles preserves fungal cells from the peptide’s toxicity
and that the metabolism of arginine is involved in the transport of
cationic peptides from vacuoles to the cytoplasm. Significantly,
cationic residues are important not only for the electrostatic
attraction and interaction with the fungal cell envelope but also for
intracellular killing mediated by PAF26 transport from the vacuole
into the cytosol.
As part of this report, we have demonstrated for the first time
the activity and cell penetrating properties of the rationally
designed peptide PAF26 against the human pathogen A. fumigatus
and then extended our previous results with other model and
economically important fungi [21,23,24]. Acute invasive pulmo-
nary aspergillosis caused by A. fumigatus is a rapidly progressive and
frequently lethal infection in immunocompromised patients [43–
45]. However, existing treatments are limited to only a small
number of antifungal drugs, such as azoles, echinocandins or
polyenes [46,47]. The identification of AMPs as promising
Table 2. Saccharomyces cerevisiae gene deletion mutants used in this study.
Strain a Genotype Description b PAF26 susceptibility c
BY4741 MATa his3D1 leu2D0 met15D0 uraD0 Parental Strain
Y04007 Same as BY4741 ipt1D::KanMX4 Inositolphosphotransferase, involved in synthesis of
the sphingolipid mannose-(inositol-P)2-ceramide [M(IP)2C]
R
Y01750 Same as BY4741 arg1D::KanMX4 Arginosuccinate synthetase (arginine biosynthesis
and urea cycle). Cytosolic.
R
Y03215 Same as BY4741 ecm33D::KanMX4 GPI-anchored protein of unknown function.
Cell wall/plasma membrane.
S
aStrain name at the EUROSCARF collection (http://web.uni-frankfurt.de/fb15/mikro/euroscarf/index.html).
bSummary of annotations found at the Saccharomyces Genome Database (http://www.yeastgenome.org/).
cSusceptibility of each strain to PAF26, as reported in [24]. ‘‘R’’ stands for increased resistance and ‘‘S’’ for increased susceptibility, respectively, as compared to the
parental strain BY4741.
doi:10.1371/journal.pone.0054813.t002
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pharmaceutical agents against this pathogen is currently being
investigated [48–51]. Previous reports have demonstrated anti-
fungal activity of AMPs against A. fumigatus in model animal
pathosystems [50] and therefore this class of antifungal agents
holds promise for the future treatment of aspergillosis. Different
AMPs have also been assayed against the related model species A.
nidulans [41]. In the present study, we found that the antifungal
activity of PAF26 inhibits conidial germination in A. fumigatus
(Figure 4A) at low micromolar concentrations, similar to that
reported previously for other fungi [17]. PAF26 is in the lower size
range of peptides that are active against this fungus although the
acylated palmitoyl-Lys-Ala-DAla-Lys tetrapeptide has also been
reported to be active against A. fumigatus [50]. The only previous
examples of antifungal peptides that have amino acid sequence
similarity to PAF26 are the larger Sub5 [41] and hLF(1–11) [49],
which are cationic and contain two and one tryptophan residues,
respectively.
The transport of PAF26 to the cytoplasm from the vacuoles of
the A. fumigatus cells induced the disappearance of the H1-GFP
fluorescence indicating the dissolution of nuclei, which occurred
just before or was coincident with cell death (Figures 4B and 5). At
no point was co-localization of H1-GFP and TMR-PAF26
observed indicating that PAF26 does not become specifically
recruited to the nucleus as previously reported for the Tat (47–58)
CP-AMP [19]. This is consistent with our observations that
correlate killing with the active transport of peptide out of the
vacuoles into the cytoplasm [17].
The novel findings described here can presumably be extended
to other AMPs with similar physicochemical properties and
functionalities as we have previously proposed [17]. It remains to
be determined whether the C-terminal hydrophobic domain of
PAF26 can direct the internalization into fungal cells of other
unrelated peptidic or even not-peptidic motifs. Future experiments
will address this issue as well as the relevance of using PAF26 as a
model for studies on other cationic AMPs.
Materials and Methods
Fungal strains and growth conditions
Microorganisms used in this work were: Neurospora crassa WT 74-
OR23-1VA matA strain (obtained from the Fungal Genetic Stock
Center, FGSC#2489), Aspergillus fumigatus CEA10 strain
(FGSC#1163) and a derivative with the histone H1 tagged with
GFP (PGpdA-H1-sGFP) were kindly provided by Drs. Joanne
Wong Sak Hoi and Jean Paul Latge´ (Pasteur Institute, Paris),
Penicillium digitatum strain PHI26 (CECT 20796) [52], and strains of
Saccharomyces cerevisiae listed in Table 2. Neurospora crassa and A.
fumigatus strains were grown in standard liquid Vogel’s medium
[53] at 35uC and 37uC respectively, and P. digitatum on potato
dextrose agar (PDA) (Difco-BD Diagnostics, Sparks, MD) plates at
24uC until the culture conidiated. Conidia were collected and
quantified with a hemocytometer to adjust to concentrations of
6.56104 conidia/ml for N. crassa and 16106 conidia/ml for A.
fumigatus in 10% Vogel’s liquid media, and to 2.56104 conidia/ml
for P. digitatum in 5% potato dextrose broth (PDB) (Difco-BD
Diagnostics) media used in the antifungal assays. S. cerevisiae strains
were grown in YPD (yeast peptone dextrose) plates and liquid
media.
Antifungal peptides
PAF26, PAF95 and PAF96 peptides (Table 1) were purchased
from GenScript (GenScript Coorp., NJ, USA) at $95% purity,
and were synthesized by solid-phase methods using N-(9-
fluorenyl)methoxycarbonyl (Fmoc) chemistry. Peptides were also
synthesized labeled with tetramethyl-rhodamine (TMR-PAF26,
TMR-PAF95 and TMR-PAF96) by covalent modification of their
N-terminus. Stock solutions of PAF26 and PAF96 peptides were
prepared at 1–5 mM in 5 mM 3-(N-morpholino)-propanesulfonic
acid (MOPS, Sigma), pH 7 buffer and stored at 220uC. PAF95
and TMR-labeled peptides were firstly dissolved in a small volume
of dimethylsulfoside (DMSO) according to the manufacturer’s
guidelines and then diluted to ,200 mM in MOPS, to keep the
DMSO concentration at less than 1% in the stock solution.
Dyes and chemicals
Fluorescent dyes included the cell death marker propidium
iodide (PI) (Sigma, MO, USA), the vacuolar marker Oregon
Green 488 carboxylic acid (cDFFDA) (Molecular Probes, OR,
USA) and the chitin binding dye calcofluor white (CFW) (Sigma).
Stock solutions were made in DMSO or water as appropriate.
Working concentrations used in live-cell imaging experiments
were 5 mg/ml for PI, 20 mM cDFFDA and 50–100 mg/ml for
CFW.
In vitro antifungal activity assays
Fungistatic activity against N. crassa and A. fumigatus was
microscopically analyzed by quantifying the percentage of
germination (germ tube formation) after 3 h at 35uC for N. crassa,
and after 4–5 h at 37uC for A. fumigatus exposed to the different
peptide concentrations (see next section). Fungistatic activity
against P. digitatum was assayed in 96-well plates as described
[22]. Fungicidal activity of peptides towards conidia of N. crassa
and A. fumigatus was determined by incubating peptide-treated
conidia with the cell death marker PI, and analysis by wide-field
fluorescence microscopy. Three replicas were analyzed for each
treatment. A minimum of 100 conidia were analyzed for each
peptide concentration in each replicate. Living and dead cells were
discriminated from each other using the PI fluorescence, as
described before [17]. Fungicidal activity against S. cerevisiae strains
was assayed as described [24] by incubation of serial 5-fold
dilutions from 16106 CFU/ml exponentially grown cells treated
with a 64 mM concentration of each peptide for 24 h, and
subsequently plating onto YPD peptide-free plates. All antifungal
activity experiments were repeated at least three times. Statistical
analyses of the distribution of PAF26 across populations of S.
cerevisiae strains were carried out with the software package
StatGraphics Plus 5.1 (StatPoint, Hemdon, VA). If necessary,
data were log transformed to fulfill the equal variance criteria of
the ANOVA tests.
Live-cell fluorescence microscopy
Techniques of live-cell imaging at high resolution optimized for
filamentous fungi have been carried out following previously
described methodologies [54,31,32]. Time-lapse confocal laser
scanning microscopy was performed using a Radiance 2100
system (Bio-Rad Microscience, Hemel Hempstead, UK) which
was mounted on a Nikon TE2000U Eclipse inverted microscope
equipped with blue diode, argon ion and HeNe lasers. Excitation
and emission wavelengths were as follows. Excitation at 405 nm
and emission at 420 nm (long pass filter) to visualize CFW
fluorescence, excitation at 488 nm and emission at 515–530 nm
(bandwidth filter) to visualize cDFFDA fluorescence, and excita-
tion at 543 nm and emission at 580–700 nm (bandwidth filter) to
visualize TMR-peptides and PI fluorescence. Simultaneous bright-
field images were captured with a transmitted light detector.
Where appropriate, Kalman filtering (n= 1) was used to improve
the signal-to-noise ratio of individual images. Laser intensity and
exposure was kept to a minimum to reduce photobeaching and
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phototoxic effects. Imaging was carried out a room temperature.
Confocal images were captured using Lasersharp software (v. 5.1,
BioRad Microscience) and were subsequently processed using
ImageJ software (v. 1.44, MacBiophotonics, Canada).
Wide-field epifluorescence imaging was also performed with an
inverted Nikon Eclipse TE2000E microscope (Nikon, Kingston-
Upon-Thames, UK) equipped with a DXM1200F camera and the
ACT-1 software for image acquisition. Propidium iodide fluores-
cence was excited at 550 nm using a CoolLED pE excitation
system (CoolLED Ltd., Hampshire, UK). A 575 nm long-pass
emission filter was used for visualization.
Live-cell imaging was performed with cells incubated in an 8-
well slide culture chambers (Nalge Nunc International, Rochester,
NY). The culture chamber was mounted on the inverted
microscope.
Supporting Information
Figure S1 Representative confocal microscopy images
from the data set of experiments shown in Figure 2A.
Localization of 5 mM of the different TMR-labeled PAF peptides
in N. crassa conidia 1 h after incubation with the peptides. The
percentage of cells with different patterns of peptide localization
are shown in Figure 2A.
(TIF)
Figure S2 Dose-response curves of the fungistatic
effects of PAF peptides on P. digitatum. Conidia were
incubated with the peptides PAF26 (black circles), PAF95 (white
triangles) and PAF96 (white squares) in 5% PDB at 24uC in
microtiter plates. Curves show the mean OD (492 nm)6 standard
deviations of three replicate samples after 72 h of incubation.
Other experimental details as described [22].
(TIF)
Movie S1 Time-lapse confocal microscopy of TMR-
PAF26 internalization, uptake into vacuoles and associ-
ated vacuolar expansion in conidia and conidial germl-
ings of A. fumigatus. In the left panel the movie shows merged
fluorescence images for TMR-PAF26 (in red) and H1-GFP labeled
nuclei (in green). In the right panel the movie shows the same cells
imaged with brightfield optics. The peptide was applied at a
concentration of 5 mM and images are shown from 5 min after
peptide addition. The time course was recorded at room
temperature with frames captured at 4.8 sec intervals over the
period of 25 min.
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